ENOVID Drug Patent Profile
✉ Email this page to a colleague
When do Enovid patents expire, and what generic alternatives are available?
Enovid is a drug marketed by Gd Searle Llc and is included in one NDA.
The generic ingredient in ENOVID is mestranol; norethynodrel. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethynodrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ENOVID?
- What are the global sales for ENOVID?
- What is Average Wholesale Price for ENOVID?
Summary for ENOVID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| DailyMed Link: | ENOVID at DailyMed |
US Patents and Regulatory Information for ENOVID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gd Searle Llc | ENOVID | mestranol; norethynodrel | TABLET;ORAL | 010976-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | ENOVID-E | mestranol; norethynodrel | TABLET;ORAL-20 | 010976-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | ENOVID | mestranol; norethynodrel | TABLET;ORAL | 010976-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | ENOVID | mestranol; norethynodrel | TABLET;ORAL-20 | 010976-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | ENOVID-E 21 | mestranol; norethynodrel | TABLET;ORAL-21 | 010976-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
